Table 1.
Item | CG2 | DT2 | DT + ARG2 | DT + NCG2 | DT + GLN2 |
---|---|---|---|---|---|
VH, μm | 463.24 ± 16.35 | 492.24 ± 44.70b | 540.01 ± 47.10b | 504.22 ± 46.11b | 799.01 ± 35.13a |
CD, μm | 133.37 ± 2.85 | 162.89 ± 18.23b∗ | 158.48 ± 12.98b | 183.70 ± 12.82b | 304.84 ± 22.28a |
H:D ratio | 3.48 ± 0.11 | 3.06 ± 0.14b | 3.45 ± 0.23a | 2.75 ± 0.18b | 2.67 ± 0.11b |
VW, μm | 43.61 ± 0.52 | 48.13 ± 2.10b | 47.75 ± 2.58b | 46.26 ± 3.14b | 70.73 ± 5.08a |
VSA, μm2 | 63,459 ± 2512 | 75,826 ± 1049b | 82,799 ± 1183b | 75,127 ± 1132b | 179,567 ± 1796a |
VH = villus height; CD = crypt depth; H:D = the ratio of villus height to crypt depth; VW = villus width; VSA = villus surface area.
Mean values within a row with the letter (*) are significantly difference (P < 0.05) for comparison between DT and CG. Mean values within a row with different letters (a and b) are significantly difference (P < 0.05) for comparison between DT, DT + ARG, DT + NCG and DT + GLN. Data are stated as mean ± SEM.
CG: control group, DT: diquat treatment, DT + ARG: diquat plus 1% arginine treatment, DT + NCG: diquat plus 0.1% N-carbamylglutamate treatment, DT + GLN: diquat plus 1% glutamine treatment.